Clinical trialNCT07213804RecruitingPhase 3Interventional

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

SponsorEli Lilly and CompanyEnrollment1,630Fallopian Tube NeoplasmsNeoplasm MetastasisOvarian NeoplasmsPeritoneal Neoplasms

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

265 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Ballarat Health Services
Ballarat Central, Australia
LeeNa Teo
Not, yet, recruiting
Chris O'Brien Lifehouse
Camperdown, Australia
Michelle Harrison
Not, yet, recruiting
Launceston General Hospital
Launceston, Australia
Jeremy Power
Not, yet, recruiting
Cabrini Hospital - Malvern
Malvern, Australia
Gary Richardson
Not, yet, recruiting
Prince of Wales Hospital
Randwick, Australia
Yeh Chen Lee
Not, yet, recruiting
Goulburn Valley Health
Shepparton, Australia
Arvind Sahu
Not, yet, recruiting
Gold Coast University Hospital
Southport, Australia
Sean Hill
Not, yet, recruiting
Royal North Shore Hospital
St Leonards, Australia
Connie Diakos
Not, yet, recruiting
the Townsville Hospital
Townsville, Australia
Joanne Tan
Not, yet, recruiting
Latrobe Regional Health
Traralgon, Australia
Bhavini Shah
Not, yet, recruiting

Austria

Medizinische Universität Graz
Graz, Austria
Vassiliki Kolovetsiou Kreiner
Not, yet, recruiting
Medizinische Universitaet Innsbruck
Innsbruck, Austria
Irina Tsibulak
Not, yet, recruiting
Universitaetsklinikum Allgemeines Krankenhaus Wien
Vienna, Austria
Stephan Polterauer
Not, yet, recruiting

Belgium

Institut Jules Bordet
Anderlecht, Belgium
Laura Polastro
Not, yet, recruiting
Az Sint-Jan Brugge-Oostende Av
Bruges, Belgium
Eveline De Cuypere
Not, yet, recruiting
Antwerp University Hospital
Edegem, Belgium
Laure-Anne Teuwen
Not, yet, recruiting
Az Maria Middelares
Ghent, Belgium
Christof Vulsteke
Not, yet, recruiting
Uz Leuven
Leuven, Belgium
Els Van Nieuwenhuysen
Recruiting

Brazil

Oncocentro de Minas Gerais
Belo Horizonte, Brazil
Angelica Rodrigues
Not, yet, recruiting
Cpam - Centro de Pesquisas Da Amazônia
Belém, Brazil
Bruno Fernandes
Not, yet, recruiting
Cepen - Centro de Pesquisa E Ensino Em Oncologia de Santa Catarina
Florianópolis, Brazil
Maria Eduarda Meyer
Not, yet, recruiting
Hospital Brasilia
Lago Sul, Brazil
Romualdo Barroso-Sousa
Not, yet, recruiting
Centro de Tratamento de Tumores Botafogo Para Oncoclinicas Rio de Janeiro Sa
Rio de Janeiro, Brazil
Alexssandra Dos Santos
Not, yet, recruiting
Instituto D'Or Pesquisa E Ensino
Rio de Janeiro, Brazil
Eduardo Paulino
Not, yet, recruiting
Clinica Amo - Rio Vermelho
Salvador, Brazil
Aknar Calabrich
Not, yet, recruiting
Centro de Oncologia - Ceon+ - Unidade São Caetano Do Sul
São Caetano do Sul, Brazil
Patricia Santi
Not, yet, recruiting

Canada

Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Canada
Prafull Ghatage
Not, yet, recruiting
Hamilton Health Sciences-Juravinski Cancer Centre
Hamilton, Canada
Nidhi Kumar Tyagi
Not, yet, recruiting
Jewish General Hospital
Montreal, Canada
Susie Lau
Not, yet, recruiting
Centre Intégré Universitaire de Santé Et de Services Sociaux de L'Estrie Centre Hospitalier Universitaire -T
Sherbrooke, Canada
Paul Bessette
Not, yet, recruiting
Bc Cancer Surrey
Surrey, Canada
Aalok Kumar
Not, yet, recruiting
Princess Margaret Cancer Centre
Toronto, Canada
Amit Oza
Not, yet, recruiting
Sunnybrook Research Institute
Toronto, Canada
Lilian Gien
Not, yet, recruiting

China

Beijing Cancer Hospital
Beijing, China
Yunong Gao
Recruiting
Peking University First Hospital
Beijing, China
Jun Hu
Recruiting
the First Hospital of Jilin University
Changchun, China
Songling Zhang
Recruiting
the First People'S Hospital of Changde City
Changde, China
Tao Wu
Recruiting
Xiangya Hospital Central South University
Changsha, China
Yu Zhang
Recruiting
Sichuan Provincial People'S Hospital
Chengdu, China
honglin hu
Not, yet, recruiting
Fujian Cancer Hospital
Fuzhou, China
An Lin
Not, yet, recruiting

225 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bevacizumab →Carboplatin →Gemcitabine →MIRVPaclitaxel →Doxorubicin →Sofetabart MipitecanTopotecan →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Oct 2025
Primary completion: 30 Nov 2028
Completion: 31 Aug 2031
Last update posted: 7 Jul 2026
Registered enrollment: 1,630
Registry id: NCT07213804

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-522255-25-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.